Chemed Corp. (NYSE:CHE) declared a dividend on Friday, November 3rd, Fidelity reports. Investors of record on Monday, November 13th will be paid a dividend of 0.28 per share on Monday, December 4th. The ex-dividend date of this dividend is Friday, November 10th.

Chemed Corp. has raised its dividend by an average of 9.6% per year over the last three years and has raised its dividend annually for the last 8 consecutive years. Chemed Corp. has a payout ratio of 23.7% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Chemed Corp. to earn $8.91 per share next year, which means the company should continue to be able to cover its $1.12 annual dividend with an expected future payout ratio of 12.6%.

Shares of Chemed Corp. (NYSE:CHE) traded up $10.56 during trading on Friday, reaching $235.01. 126,539 shares of the company were exchanged, compared to its average volume of 92,810. The stock has a market capitalization of $3.67 billion, a PE ratio of 28.31, a price-to-earnings-growth ratio of 4.86 and a beta of 1.14. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.48 and a current ratio of 0.50.

Chemed Corp. (NYSE:CHE) last announced its quarterly earnings data on Thursday, October 26th. The company reported $2.15 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.00 by $0.15. The firm had revenue of $417.40 million during the quarter, compared to analysts’ expectations of $414.34 million. Chemed Corp. had a return on equity of 27.69% and a net margin of 4.62%. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the business posted $1.73 EPS. equities research analysts expect that Chemed Corp. will post 4.73 EPS for the current fiscal year.

A number of analysts have recently commented on CHE shares. KeyCorp reaffirmed a “hold” rating on shares of Chemed Corp. in a research note on Friday, October 27th. Zacks Investment Research cut Chemed Corp. from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $209.00 price target on shares of Chemed Corp. in a research note on Tuesday, October 3rd. BidaskClub lowered Chemed Corp. from a “buy” rating to a “hold” rating in a research report on Wednesday, August 2nd. Finally, Oppenheimer Holdings, Inc. boosted their price objective on Chemed Corp. from $220.00 to $225.00 and gave the company an “outperform” rating in a research report on Friday, October 27th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $236.00.

In related news, CEO Kevin J. Mcnamara sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 31st. The stock was sold at an average price of $223.42, for a total value of $2,234,200.00. Following the completion of the transaction, the chief executive officer now directly owns 170,016 shares in the company, valued at approximately $37,984,974.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Naomi C. Dallob sold 750 shares of the business’s stock in a transaction that occurred on Tuesday, October 31st. The shares were sold at an average price of $222.09, for a total value of $166,567.50. Following the completion of the transaction, the vice president now owns 9,097 shares of the company’s stock, valued at $2,020,352.73. The disclosure for this sale can be found here. Insiders sold a total of 13,250 shares of company stock valued at $2,927,418 over the last quarter. 4.90% of the stock is owned by insiders.

COPYRIGHT VIOLATION NOTICE: “Chemed Corp. to Issue Dividend of $0.28 (CHE)” was posted by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another site, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/11/04/chemed-corp-to-issue-dividend-of-0-28-che.html.

About Chemed Corp.

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Dividend History for Chemed Corp. (NYSE:CHE)

Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.